Remove Innovation Remove Medicare Remove Outcomes
article thumbnail

New Tool Helps Predict Stroke Outcome with Higher Accuracy

DAIC

We are entering a new era of stroke care where data-driven insights guide every decision, said Bazan, senior author and the John Ochsner Professor of Cardiovascular Innovation at Ochsner Health. Stroke care presents distinct challenges that require swift action and informed decisions.

Strokes 52
article thumbnail

Cleerly Raises $106 Million in Series C Extension Funding

DAIC

With this new funding, Cleerly will continue to scale its commercial growth and clinical evidence generation, helping health care professionals improve outcomes for patients across the coronary care pathway. We’re proud to be a part of Cleerly’s journey.

article thumbnail

GE Healthcare Launches New Cardiac PET tracer

DAIC

This launch coincides with the receipt of pass-through status by the CMS, effectiveApril 1, securing a drug-specific Healthcare Common Procedure Coding System (HCPCS) billing code and coverage for traditional Medicare beneficiaries.

article thumbnail

Bridging the Gap: Enhancing Stroke Recovery Through Digital Health Solutions

DAIC

To improve outcomes and be in compliance with new regulations, it's crucial to better identify and address these issues during the recovery period. With the rise of digital health, innovative solutions are emerging that can significantly impact patient care and recovery while simultaneously addressing health equity.

Strokes 115
article thumbnail

Revolution Vibe CT System Now Available from GE Healthcare

DAIC

vii Similarly, recent increases in Medicare reimbursement rates for CCTA are a positive step towards making this technology more accessible. This innovative technology maximizes operational efficiency, enhances staff expertise, and delivers better patient outcomes, making it a wise long-term investment. 2012) 380:2095128.

article thumbnail

FDA Breakthrough Device Designation for Biotronik Freesolve Below-the-Knee Resorbable Magnesium Scaffold (RMS)

DAIC

“Biotronik 's focus on vascular interventional excellence is evident in our strategic investments and persistent dedication to innovation”, said Dr. Jörg Pochert, President of Vascular Intervention at Biotronik. For more information: www.biotronik.com References: 1 Kwong M.,

article thumbnail

iRhythm Unveils New Data Demonstrating Benefits of Long-Term Continuous Monitoring for Arrhythmia Detection

DAIC

These findings challenge the long-held assumption that frequent symptoms justify short-duration monitoring, said Mintu Turakhia, MD, iRhythm Chief Medical and Scientific Officer and EVP of Product Innovation. Long-term outcome of non-sustained ventricular tachycardia in structurally normal hearts. The American Journal of Cardiology.